POLITICSEURACTIV
Socialist MEPs face challenge on Biotech Act push to scrap drug patent protections
Socialist MEPs are facing a challenge over the Biotech Act, which aims to scrap drug patent protections. The conservative EPP and Renew groups are expected to support the proposal.
Mentioned
Related Signal
Adjacent reporting
- Patent clash threatens EU gene‑edited crops deal
- STAT+: U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
- STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
- Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies
- ‘Fast-track’ regulation could expose Britons to harmful chemicals, say campaigners